CompanyIMNNNasdaqLawrenceville, NJ

Imunon

IMUNON is a clinical-stage biotechnology company developing non-viral DNA therapies.

SEC EDGAR ClinicalTrials.gov imunon.com

8-KSep 29Latest SEC filing

Sep 29Latest story

September 2026

Imunon exchanges part of promissory note for new Series B Preferred Stock

Sep 29FinancingImunon

August 2026

Imunon lets three top executives take part of salary in stock through September

Aug 11PeopleImunon

Imunon reports Q2 2026 results, cites OVATION 3 enrollment pace and new MRD data

Aug 11Quarterly updateImunon

June 2026

Imunon names Josh Blacher interim CFO as Jeffrey Church retires

Jun 30PeopleImunon